News tagged with her2
Antibody-guided drug shows encouraging activity in metastatic breast cancer
Dec 12, 2009 |
5 / 5 (1) |
0
A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from ...
Targeted therapy prolongs life in patients with HER2-positive breast cancer
Dec 11, 2009 |
5 / 5 (1) |
0
Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive, according to Kimberly Blackwell, M.D., associate professor of medicine ...
Combining nanotubes and antibodies for breast cancer 'search and destroy' missions
Dec 02, 2009 |
5 / 5 (1) |
0
cylinders of carbon about a nanometer in diameter -- have been highly touted for potential applications such as ultrastrong fibers, electrical wires in molecular devices, or hydrogen storage components for ...
Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?
Oct 16, 2009 |
not rated yet |
0
A research team from Germany analyzed the pathogenetic role and potential clinical usefulness of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) in patients with advanced ...
African American lung cancer patients may have different response to new cancer-fighting drugs
Oct 07, 2009 |
not rated yet |
0
Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response ...
Information about the use and accuracy of breast cancer tests is lacking, study finds
Sep 14, 2009 |
not rated yet |
4
A new study finds that there is little information available about the use of new testing technologies and targeted therapies in breast cancer, specifically the anti-cancer drug trastuzumab (Herceptin). Published in the November ...
Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
May 28, 2009 |
not rated yet |
0
Fox Chase Cancer Center researchers report that a combination of trastuzumab and neratinib (HKI-272) a novel small molecule inhibitor of the HER2 receptor (ErbB2) appears active in women with HER2-positive metastatic breast ...
African-American women with advanced breast cancer often forego vital treatment
May 22, 2009 |
not rated yet |
1
A new study finds that nearly one in four African American women with late stage breast cancer refused chemotherapy and radiation therapy, potentially life saving therapies. Published in the July 1, 2009 issue of Cancer, a peer ...
New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice
Mar 30, 2009 |
5 / 5 (1) |
0
Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, ...
Risk of aggressive breast cancer subtype three times higher for black women
Mar 25, 2009 |
5 / 5 (1) |
2
Lifestyle, age and weight have all been considered as risk factors for breast cancer. Now a study published in the open access journal Breast Cancer Research has found that even taking these factors into consideration, black ...
